title: Shorter interpuff interval is associated with higher nicotine intake in smokers with schizophrenia.
abstract: BACKGROUND
  People with schizophrenia are frequent and heavy smokers.
  
  
  METHODS
  The objective of this study was to measure serum nicotine levels and ad libitum smoking behavior for 24+2h using the CReSS micro topography device in 75 smokers with schizophrenia (SCZ) and compare these to 86 control smokers (CON) without mental illness. Mean values of repeatedly measured topography variables were compared using three-level nested linear models to adjust for between subject differences and the double nested data.
  
  
  RESULTS
  Smokers with SCZ smoked more cigarettes in the 24h period and took an average of 2.8 more puffs per cigarette than CON (p<0.001). The time between puffs, or interpuff interval (IPI), was shorter in SCZ by an average of 6.5s (p<0.001). The peak flow rate was higher in SCZ by an average of 4.9 ml/s (p<0.05). Smokers with SCZ spent an average of 1.0 min less time smoking a single cigarette vs. CON (p<0.001). Smokers with SCZ also had shorter IPI and more puffs per cigarette in an analysis of first cigarette of the day. For all subjects, a decrease in IPI by 1s was associated with an increase in serum nicotine of 0.19 ng/ml and in cotinine of 5.01 ng/ml (both p<0.05). After controlling for diagnosis group, higher craving scores on QSU Factor 2 (urgent desire to smoke) were associated with shorter IPI.
  
  
  CONCLUSIONS
  Smokers with schizophrenia demonstrate more intense cigarette puffing that is associated with greater nicotine intake. This pattern may provide insight into other heavily dependent smokers.
authors: UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ 08901-2008, USA. jill.williams@umdnj.edu
authors: Jill M
authors: JM
authors: Williams
authors: Kunal K
authors: KK
authors: Gandhi
authors: Shou-En
authors: SE
authors: Lu
authors: Supriya
authors: S
authors: Kumar
authors: Marc L
authors: ML
authors: Steinberg
authors: Brett
authors: B
authors: Cottler
authors: Neal L
authors: NL
authors: Benowitz
references: J Psychiatr Res. 1975 Nov;12(3):189-98
references: 1202204
references: Schizophr Res. 2009 Dec;115(2-3):317-24
references: 19700263
references: Addict Behav. 2007 Apr;32(4):793-802
references: 16839695
references: Curr Med Res Opin. 2004 Jul;20(7):1057-74
references: 15265251
references: Drug Alcohol Depend. 2005 Nov 1;80(2):259-65
references: 15869844
references: Clin Pharmacol Ther. 1984 Apr;35(4):499-504
references: 6705448
references: Drug Alcohol Depend. 2007 Oct 8;90(2-3):234-42
references: 17482773
references: Br J Psychiatry. 2000 Sep;177:212-7
references: 11040880
references: Nicotine Tob Res. 2001 Feb;3(1):7-16
references: 11260806
references: Am J Psychiatry. 2003 Feb;160(2):316-22
references: 12562579
references: Pharmacol Biochem Behav. 1990 Sep;37(1):29-39
references: 2263664
references: Nicotine Tob Res. 2008 Jun;10(6):1047-56
references: 18584468
references: Psychopharmacology (Berl). 1992;106(3):421-7
references: 1570391
references: Nicotine Tob Res. 2010 Aug;12(8):855-9
references: 20584771
references: Neuropsychopharmacology. 2002 Sep;27(3):479-97
references: 12225705
references: Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):154-7
references: 16434603
references: Br Med J (Clin Res Ed). 1981 Sep 26;283(6295):814-7
references: 6794710
references: Biol Psychiatry. 2001 Jul 15;50(2):71-83
references: 11526998
references: J Clin Psychiatry. 2003 Jun;64(6):663-7
references: 12823080
references: J Pers Soc Psychol. 1988 Jun;54(6):1063-70
references: 3397865
references: Br J Addict. 1991 Nov;86(11):1467-76
references: 1777741
references: Schizophr Res. 2005 Nov 15;79(2-3):323-35
references: 15961287
references: Br J Psychiatry Suppl. 1989 Nov;(7):59-67
references: 2619982
references: JAMA. 2000 Nov 22-29;284(20):2606-10
references: 11086367
references: Cancer Epidemiol Biomarkers Prev. 2003 May;12(5):468-71
references: 12750245
references: Schizophr Res. 2008 Jan;98(1-3):287-94
references: 18031996
references: Neuropsychopharmacology. 1998 Mar;18(3):175-85
references: 9471115
references: Neuropsychopharmacology. 2002 Jan;26(1):75-85
references: 11751034
references: Drug Alcohol Depend. 2009 May;101(3):191-5
references: 19264427
references: Addict Behav. 2005 Jan;30(1):49-59
references: 15561448
references: Br J Addict. 1991 Sep;86(9):1119-27
references: 1932883
references: Psychol Rev. 2004 Jan;111(1):33-51
references: 14756584
references: Schizophr Res. 2007 Mar;91(1-3):217-25
references: 17293085
references: Am J Psychiatry. 1993 Dec;150(12):1856-61
references: 8238642
references: Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3415-20
references: 19959690
references: Drug Alcohol Depend. 2010 Jul 1;110(1-2):151-5
references: 20227198
references: Psychol Addict Behav. 2010 Dec;24(4):724-729
references: 21198231
references: J Clin Psychiatry. 2004 May;65(5):715-20
references: 15163261
references: J Chem Neuroanat. 2000 Dec;20(3-4):299-306
references: 11207427
references: Am Rev Respir Dis. 1982 Aug;126(2):258-64
references: 7103252
references: Nicotine Tob Res. 2003 Oct;5(5):673-9
references: 14577984
references: Clin Pharmacol Ther. 2004 Jul;76(1):64-72
references: 15229465
references: Br J Addict. 1989 Mar;84(3):301-7
references: 2650770
references: Psychopharmacology (Berl). 1999 Jul;145(1):1-20
references: 10445368
references: Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1370-5
references: 15941943
references: Nicotine Tob Res. 2009 Jul;11(7):896-903
references: 19525207
references: Am J Psychiatry. 1991 Feb;148(2):224-30
references: 1987823
references: J Natl Cancer Inst. 2000 Jan 19;92(2):106-11
references: 10639511
references: Acta Psychiatr Scand Suppl. 1985;320:38-42
references: 2931947
references: Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1578-83
references: 19423535
references: Schizophr Res. 2005 Jul 15;76(2-3):135-57
references: 15949648
references: Cancer Epidemiol Biomarkers Prev. 2004 Nov;13(11 Pt 1):1800-4
references: 15533910
references: Nicotine Tob Res. 2003 Oct;5(5):621-4
references: 14577978
references: Biol Psychiatry. 1997 Jul 1;42(1):1-5
references: 9193735